Leonardi A, Rosani U, Cavarzeran F, Daull P, Garrigue JS, Paola B. Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19. Allergy. 2021 Aug 14:10.1111/all.15048. doi: 10.1111/all.15048.

Leonardi A, Daull P, Garrigue JS, et al. Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis. Ocul Surf. 2021;19:241-248. doi: 10.1016/j.jtos.2020.09.009.

Leonardi A, Modugno RL, Cavarzeran F, Rosani U. Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis. Allergy. 2021 May 28. doi: 10.1111/all.14963.

Leonardi A, Salami E, Feuerman OM, Cavarzeran F. The effects of the COVID-19 pandemic on the treatment of allergic eye diseases. Curr Opin Allergy Clin Immunol. 2021;21(5):500-506. doi: 10.1097/ACI.0000000000000766. PMID: 34269742.

Messina A, Palmigiano A, Tosto C, Romeo DA, Sturiale L, Garozzo D, Leonardi A. Tear N-glycomics in vernal and atopic keratoconjunctivitis. Allergy. 2021;76(8):2500-2509. doi: 10.1111/all.14775.

Leonardi A, Modugno RL, Salami E. Allergy and Dry Eye Disease. Ocul Immunol Inflamm. 2021 Feb 5:1-9. doi: 10.1080/09273948.2020.1841804.

Ferrari S, Del Vecchio C, Leonardi A, et al. Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors. Acta Ophthalmol. 2020 Dec 16. doi: 10.1111/aos.14692.

Leonardi A, Fauquert JL, Doan S, et al. Managing ocular allergy in the time of COVID-19. Allergy. 2020 Sep;75(9):2399-2402. doi: 10.1111/all.14361. Epub 2020 May 25. PMID: 32402114; PMCID: PMC7273086.

Brun P, Tarricone E, Di Stefano A, Mattiuzzo E, Mehrbod P, Ghavami S, Leonardi A. The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis. J Allergy Clin Immunol. 2020 doi: 10.1016/j.jaci.2020.03.013

Leonardi A, Rosani U, Brun P. Ocular Surface Expression of SARS-CoV-2 Receptors. Ocul Immunol Inflamm. 2020;28(5):735-738. doi: 10.1080/09273948.2020.1772314.

Leonardi A, Dupuis-Deniaud M, Bremond-Gignac D. Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score. J Mark Access Health Policy. 2020;8(1):1748492. doi: 10.1080/20016689.2020.1748492.

Bielory L, Delgado L, Katelaris CH, Leonardi A, Rosario N, Vichyanoud P. ICON: Diagnosis and management of allergic conjunctivitis. Ann Allergy Asthma Immunol. 2020;124(2):118-134. doi: 10.1016/j.anai.2019.11.014.

Leonardi A, Carraro G, Modugno RL, et al. Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy. Br J Ophthalmol. 2019 Aug 10. pii: bjophthalmol-2019-314249. doi: 10.1136/bjophthalmol-2019-314249.

Modugno RL, Scalora T, Bonaldo A, Lazzarini D, Leonardi A. Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine. Ocul Immunol Inflamm. 2020,10:1-7. doi: 10.1080/09273948.2020.1745243.

Bremond-Gignac D, Doan S, Amrane M, Ismail D, Montero J, Németh J, Aragona P, Leonardi A. 12-Month Results of Cyclosporine A Cationic Emulsion in a Randomized, Study in Patients With Pediatric Vernal Keratoconjunctivitis. Am J Ophthalmol. Am J Ophthalmol. 2020 212:116-126 doi: 10.1016/j.ajo.2019.11.020

Leonardi A, Silva D, Perez Formigo D, et al. Management of ocular allergy. Allergy. 2019;74(9):1611-1630. doi: 10.1111/all.13786.

Leonardi A, Borghesan F, Scalora T, Modugno RL, Bonaldo A. Office-based ocular procedures for the allergist. Curr Opin Allergy Clin Immunol. 2019;19(5):488-494. doi: 10.1097/ACI.0000000000000563.

Leonardi A, Doan S, Amrane M, et al. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Ophthalmology. 2019;126(5):671-681. doi: 10.1016/j.ophtha.2018.12.027.

Leonardi A, Messmer EM, Labetoulle M, et al. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies. Br J Ophthalmol. 2019;103(1):125-131. doi: 10.1136/bjophthalmol-2017-311801.

Leonardi A, Capobianco D, Benedetti N, et al. Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops. Ocul Immunol Inflamm. 2019;27(8):1352-1356. doi: 10.1080/09273948.2018.1530363.

Nguyen QD, Merrill PT, Sepah YJ, Ibrahim MA, Banker A, Leonardi A, Chernock M, Mudumba S, Do DV. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies. Ophthalmology. 2018;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015.

Leonardi A, Lazzarini D, La Gloria Valerio A, et al. Corneal staining patterns in vernal keratoconjunctivitis: the new VKC-CLEK scoring scale. Br J Ophthalmol. 2018;102(10):1448-1453. doi: 10.1136/bjophthalmol-2017-311171.

Labetoulle M, Leonardi A, Amrane M, et al. Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study. Clin Ther. 2018 Nov;40(11):1894-1906. doi: 10.1016/j.clinthera.2018.09.012. Epub 2018 Oct 30. PMID: 30389343.

Bonini S, Lambiase A, Rama P, Filatori I, Allegretti M, Chao W, Mantelli F; REPARO Study Group. Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018 Sep;125(9):1468-1471. doi: 10.1016/j.ophtha.2018.03.004.

Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, Mantelli F; REPARO Study Group. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018 Sep;125(9):1332-1343. doi: 10.1016/j.ophtha.2018.02.022.

Reyes NJ, Yu C, Mathew R, Kunnen CM, Kalnitsky J, Redfern RL, Leonardi A, Perez VL, MacLeod AS, Gupta PK, Saban DR. Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. Sci Transl Med. 2018 Jul 25;10(451):eaas9164. doi: 10.1126/scitranslmed.aas9164.

Leonardi A, Doan S, Fauquert JL, et al. Diagnostic tools in ocular allergy. Allergy. 2017;72(10):1485-1498.

Leonardi A, Van Setten G, Amrane M, Ismail D, Garrigue JS, Figueiredo FC, Baudouin C. Author's Reply to: "Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease". Eur J Ophthalmol. 2017 Nov 8;27(6):e194-e195. doi: 10.5301/ejo.5001043.

Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, Calder V, Silva D, Kvenshagen BK, Callebaut I, Allegri P, Santos N, Doan S, Perez Formigo D, Chiambaretta F, Delgado L, Leonardi A. Conjunctival allergen provocation test: guidelines for daily practice. Allergy. 2017;72(1):43-54. doi: 10.1111/all.12986.

Baudouin C, Figueiredo FC, Messmer EM, Ismail D, Amrane M, Garrigue JS, Bonini S, Leonardi A. A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. Eur J Ophthalmol. 2017 Aug 30;27(5):520-530. doi: 10.5301/EJO.5000952.

Leonardi A, Flamion B, Baudouin C. Keratitis in Dry Eye Disease and Topical Ciclosporin A. Ocul Immunol Inflamm. 2017 Aug;25(4):577-586. doi: 10.1080/09273948.2016.1276933.

Maggioni F, Leonardi A. Does Ocular Neuropathic Pain Deserve an Autonomous Position in the IHS Classification? Clinical and Diagnostic Evidences. Headache. 2017;57):962-963. doi: 10.1111/head.13080.

Di Stefano A, Ricciardolo FLM, Caramori G, Adcock IM, Chung KF, Barnes PJ, Brun P, Leonardi A, Andò F, Vallese D, Gnemmi I, Righi L, Cappello F, Balbi B. Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. Eur Respir J. 2017 May 23;49(5):1602006. doi: 10.1183/13993003.02006-2016.

Labbé A, Baudouin C, Ismail D, Amrane M, Garrigue JS, Leonardi A, Figueiredo FC, Van Setten G, Labetoulle M. Pan-European survey of the topical ocular use of cyclosporine A. J Fr Ophtalmol. 2017 Mar;40(3):187-195. doi: 10.1016/j.jfo.2016.12.004.

Leonardi A, Van Setten G, Amrane M, Ismail D, Garrigue JS, Figueiredo FC, Baudouin C. Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial. Eur J Ophthalmol. 2016 Jun 10;26(4):287-96. doi: 10.5301/ejo.5000779.

Leonardi A, Tarricone E, Corrao S, Alaibac M, Corso AJ, Zavan B, Venier P, Conway de Macario E, Macario AJ, Di Stefano A, Cappello F, Brun P. Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli. Allergy. 2016 Mar;71(3):403-11. doi: 10.1111/all.12814.